Company Filing History:
Years Active: 2024
Title: Michael Fischbach: Innovator in Treg Modulation
Introduction
Michael Fischbach is a prominent inventor based in Stanford, CA. He has made significant contributions to the field of immunology, particularly in the modulation of T regulatory lymphocytes (Tregs). His innovative work has the potential to impact the treatment of various inflammatory and autoimmune conditions.
Latest Patents
Fischbach holds a patent for "Steroid compounds as Treg modulators and uses thereof." This patent describes steroid compounds that can be formulated into pharmaceutical compositions. These compounds are designed to promote the differentiation of T regulatory lymphocytes and can be utilized in the prevention and treatment of a range of conditions in mammals, including humans. These conditions encompass inflammatory disorders, autoimmune diseases, and graft-versus-host disease.
Career Highlights
Throughout his career, Michael Fischbach has been associated with prestigious institutions such as New York University and Cornell University. His work at these institutions has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in immunology.
Collaborations
Fischbach has worked alongside notable colleagues, including Dan R Littman and Jun R Huh. These collaborations have further enriched his research and expanded the impact of his innovations in the field.
Conclusion
Michael Fischbach's contributions to Treg modulation through his patented steroid compounds represent a significant advancement in immunological research. His work holds promise for improving treatment options for various medical conditions.